Giving healthcare companies and their stories the exposure they deserve.

THIS WEEK'S FEATURE

Features

Feb 12, 2019

ImpediMed sees revenue upswing from new SaaS business model

Feb 12, 2019

ImpediMed’s (ASX:IPD) transition to a software-as-a-service (SaaS) subscription business model in 2018, in conjunction with the introduction of the SOZO Digital Health Platform, is already paying off on the top line.

Feb 12, 2019

Past Features

Featured

Feb 5, 2019

Interface Biologics to focus future growth in biotech with local drug delivery platform

Feb 5, 2019

Closely-held Interface Biologics, best known for improving the safety and efficacy of medical devices through its Endexo surface modification technology, is pegging its future growth on biotech, with an initial focus on unmet needs in ophthalmology.

Feb 5, 2019

Jan 29, 2019

Karius diagnostic test enabling precision medicine for infectious diseases

Jan 29, 2019

Closely-held Karius has developed and commercialized a next-generation sequencing test that can identify and quantify microbial cell-free DNA from more than 1,300 bacteria, viruses, fungi and parasites using a non-invasive blood sample.

Jan 29, 2019

Jan 22, 2019

Novavax to report key vaccine data in first quarter

Jan 22, 2019

Novavax (NASDAQ:NVAX) is scheduled to report pivotal data in the current quarter for ResVax, its RSV (respiratory syncytial virus) F vaccine, using aluminum phosphate as an adjuvant, in infants via maternal immunization.

Jan 22, 2019

Jan 15, 2019

Titan Pharma relaunch of Probuphine paying early dividends

Jan 15, 2019

Titan Pharmaceuticals’ (NASDAQ:TTNP) relaunch of its Probuphine implant for the long-term maintenance treatment of opioid use disorder (OUD) demonstrated promising results with a meaningful increase in product shipments in the second half of 2018.

Jan 15, 2019